These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37694290)

  • 21. Fatal myocarditis after the first dose of nivolumab.
    Zomborska E; Kasperova S; Slopovsky J; Pazderová N; Kasperova B; Penz P; Nyitrayová O; Salek T; Porsok S; Mladosievicova B; Mego M
    Klin Onkol; 2022; 35(6):486-492. PubMed ID: 36513516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and Management of Immune Checkpoint Inhibitor-Related Myocarditis: Use Troponin Wisely.
    Spallarossa P; Tini G; Sarocchi M; Arboscello E; Grossi F; Queirolo P; Zoppoli G; Ameri P
    J Clin Oncol; 2019 Sep; 37(25):2201-2205. PubMed ID: 31084547
    [No Abstract]   [Full Text] [Related]  

  • 23. Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report.
    Delombaerde D; Vervloet D; Berwouts D; Beckers R; Prenen H; Peeters M; Gremonprez F; Croes L; Vulsteke C
    J Med Case Rep; 2022 Jul; 16(1):275. PubMed ID: 35831829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Diverse Range of Cardiac Adverse Events Associated with Immune Checkpoint Inhibitor Therapy.
    Murakata Y; Tajiri K
    Intern Med; 2022 Jul; 61(14):2099-2100. PubMed ID: 35283387
    [No Abstract]   [Full Text] [Related]  

  • 25. Fatal association of fulminant myocarditis and rhabdomyolysis after immune checkpoint blockade.
    Tomoaia R; Beyer RȘ; Pop D; Minciună IA; Dădârlat-Pop A
    Eur J Cancer; 2020 Jun; 132():224-227. PubMed ID: 32336614
    [No Abstract]   [Full Text] [Related]  

  • 26. An Autopsy Case of Late-onset Fulminant Myocarditis Induced by Nivolumab in Gastric Cancer.
    Naganuma K; Horita Y; Matsuo K; Miyama Y; Mihara Y; Yasuda M; Nakano S; Hamaguchi T
    Intern Med; 2022 Oct; 61(19):2867-2871. PubMed ID: 35249925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data.
    Makunts T; Saunders IM; Cohen IV; Li M; Moumedjian T; Issa MA; Burkhart K; Lee P; Patel SP; Abagyan R
    Sci Rep; 2021 Aug; 11(1):17324. PubMed ID: 34462476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis.
    Salem JE; Allenbach Y; Vozy A; Brechot N; Johnson DB; Moslehi JJ; Kerneis M
    N Engl J Med; 2019 Jun; 380(24):2377-2379. PubMed ID: 31189043
    [No Abstract]   [Full Text] [Related]  

  • 29. Fulminant Myocarditis Caused by an Immune Checkpoint Inhibitor: A Case Report With Pathologic Findings.
    Imai R; Ono M; Nishimura N; Suzuki K; Komiyama N; Tamura T
    J Thorac Oncol; 2019 Feb; 14(2):e36-e38. PubMed ID: 30391574
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors.
    Baik AH; Tsai KK; Oh DY; Aras MA
    Clin Sci (Lond); 2021 Mar; 135(5):703-724. PubMed ID: 33686402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune Checkpoint Inhibitor Toxicity in 2018.
    Johnson DB; Chandra S; Sosman JA
    JAMA; 2018 Oct; 320(16):1702-1703. PubMed ID: 30286224
    [No Abstract]   [Full Text] [Related]  

  • 32. Multi-organ Immune-Related Adverse Event Is a Risk Factor of Immune Checkpoint Inhibitor-Associated Myocarditis in Cancer Patients: A Multi-center Study.
    Xie X; Wang L; Li Y; Xu Y; Wu J; Lin X; Lin W; Mai Q; Chen Z; Zhang J; Xie Z; Qin Y; Liu M; Lu M; Luo B; Zhou C
    Front Immunol; 2022; 13():879900. PubMed ID: 35924238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune Checkpoint Inhibitor Rechallenge in a Patient With Previous Fulminant Myocarditis.
    Menachery SM; Hang Y; Pritchard L; Poklepovic A; Bottinor W
    Am J Cardiol; 2023 Jul; 199():33-36. PubMed ID: 37245247
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy.
    Balanescu DV; Donisan T; Palaskas N; Lopez-Mattei J; Kim PY; Buja LM; McNamara DM; Kobashigawa JA; Durand JB; Iliescu CA
    Cardiovasc Pathol; 2020; 47():107211. PubMed ID: 32268262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Lack of Biomarkers for Cardiac Complications of Immune Checkpoint Inhibitor Therapy.
    Li S; Tajiri K
    Intern Med; 2021 Feb; 60(3):325-326. PubMed ID: 32963172
    [No Abstract]   [Full Text] [Related]  

  • 36. A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma.
    Matsui H; Kawai T; Sato Y; Ishida J; Kadowaki H; Akiyama Y; Yamada Y; Nakamura M; Yamada D; Akazawa H; Suzuki M; Komuro I; Kume H
    Int Heart J; 2020 Sep; 61(5):1070-1074. PubMed ID: 32921673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocarditis associated with immune checkpoint inhibitor therapy: a case report of three patients.
    Ansari-Gilani K; Tirumani SH; Smith DA; Nelson A; Alahmadi A; Hoimes CJ; Ramaiya NH
    Emerg Radiol; 2020 Aug; 27(4):455-460. PubMed ID: 32130542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute fatal myocarditis after a single dose of anti-PD-1 immunotherapy, autopsy findings: a case report.
    Hardy T; Yin M; Chavez JA; Ivanov I; Chen W; Nadasdy T; Brodsky SV
    Cardiovasc Pathol; 2020; 46():107202. PubMed ID: 32062109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete Atrioventricular Block Associated with Pembrolizumab-induced Acute Myocarditis: The Need for Close Cardiac Monitoring.
    Katsume Y; Isawa T; Toi Y; Fukuda R; Kondo Y; Sugawara S; Ootomo T
    Intern Med; 2018 Nov; 57(21):3157-3162. PubMed ID: 29877257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune checkpoint inhibitor-mediated myasthenia gravis with focal subclinical myocarditis progressing to symptomatic cardiac disease.
    Leaver PJ; Jang HS; Vernon ST; Fernando SL
    BMJ Case Rep; 2020 May; 13(5):. PubMed ID: 32404371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.